Repligen Corp (RGEN) Files Form 4 Insider Selling : Thomas F Jr Ryan Sells 10,000 Shares

Repligen Corp (RGEN): Thomas F Jr Ryan , director of Repligen Corp sold 10,000 shares on Jun 28, 2016. The Insider selling transaction was reported by the company on Jun 29, 2016 to the Securities and Exchange Commission. The shares were sold at $24.59 per share for a total value of $245,888.00 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on May 13, 2016, Howard Benjamin (other) sold 2,889 shares at $26.72 per share price.On May 19, 2015, James R Rusche (Senior Vice President) sold 15,000 shares at $41.32 per share price.Also, On May 14, 2015, Walter C Herlihy (PRESIDENT, CEO) sold 45,431 shares at $38.97 per share price.On May 12, 2015, Thomas F Jr Ryan (director) sold 20,000 shares at $37.19 per share price.

Shares of Repligen Corporation (RGEN) ended Monday, Jun 27, 2016 session in red amid volatile trading. The shares closed down -0.21 points or -0.89% at $23.46 with 4,00,411 shares getting traded. Post opening the session at $23.37, the shares hit an intraday low of $23.31 and an intraday high of $23.86 and the price vacillated in this range throughout the day. The company has a market cap of $789 M and the number of outstanding shares has been calculated to be 3,36,38,643 shares. The 52-week high of Repligen Corporation is $42.48 and the 52-week low is $20.07.

Repligen Corporation Money Flow Index Chart

Repligen Corporation (Repligen) is a life sciences company. The Company develops manufactures and markets bioprocessing products for life sciences and biopharmaceutical companies across the world. The Company is a manufacturer of both native and recombinant forms of Protein A critical reagents used in biomanufacturing to purify monoclonal antibodies which is a type of biologic drug. It also supplies several growth factor products and cell filtration products used to increase cell culture productivity during the bioproduction process. It has developed a series of OPUS chromatography columns for use in clinical-scale manufacturing. It manufactures and sells Protein A and growth factors to life sciences companies under supply agreements and sells chromatography columns as well as media and quality test kits and the Company’s Alternating Tangential Flow (ATF) products directly to biopharmaceutical companies or contract manufacturing organizations or through distributors.

Leave a Reply

Repligen Corporation - Is it time to Sell?

Top Brokerage Firms are advising their investors on Repligen Corporation. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.